Dr. Araki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bethesda, MD 20814Phone+1 301-827-1467Fax+1 301-594-1290
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
University of WashingtonResidency, Internal Medicine, 2012 - 2015
United States Naval Hospital OkinawaTransitional Internship, 2011 - 2012- Kanazawa University HospitalTransitional Internship, 2009 - 2011
Kanazawa UniversityClass of 2009
Certifications & Licensure
WA State Medical License 2014 - 2025
DC State Medical License 2016 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Abstract Achievement Award American Society of Hematology, 2015
- Honorable Distinction Award Society of Hematologic Oncology, 2015
Publications & Presentations
PubMed
- 141 citationsPre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid LeukemiaYi Zhou, Megan Othus, Daisuke Araki, Brent L. Wood, Jerald P. Radich
Leukemia. 2016-02-29 - 300 citationsAllogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission?Daisuke Araki, Brent L. Wood, Megan Othus, Jerald P. Radich, Anna B. Halpern
Journal of Clinical Oncology. 2016-09-19 - 11 citationsNOTCH-mediated ex vivo expansion of human hematopoietic stem and progenitor cells by culture under hypoxia.Daisuke Araki, Jian Fei Fu, Heather D. Huntsman, Stefan Cordes, Fayaz Seifuddin
Stem Cell Reports. 2021-09-14
Books/Book Chapters
Press Mentions
MRD Status at Time of Transplant Important Predictor of Risk for AMLDecember 18th, 2015
Professional Memberships
- Member
- Associate Member
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
